These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 28767981)
1. Protection mediated by chemokine CXCL10 in BALB/c mice infected by Leishmania infantum. Figueiredo WME; Viana SM; Alves DT; Guerra PV; Coêlho ZCB; Barbosa HS; Teixeira MJ Mem Inst Oswaldo Cruz; 2017 Aug; 112(8):561-568. PubMed ID: 28767981 [TBL] [Abstract][Full Text] [Related]
2. CXCL10 treatment promotes reduction of IL-10 Eufrásio de Figueiredo WM; Heredia FF; Santos AS; da Rocha Braga R; Marciano Fonseca FR; Lúcia de Castro Rodrigues N; Abreu TM; Maria de Lima Pompeu M; Barbosa HS; Teixeira MJ Exp Parasitol; 2019 Dec; 207():107789. PubMed ID: 31669169 [TBL] [Abstract][Full Text] [Related]
3. Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system. Duarte MC; Lage LM; Lage DP; Martins VT; Carvalho AM; Roatt BM; Menezes-Souza D; Tavares CA; Alves RJ; Barichello JM; Coelho EA Parasitol Int; 2016 Dec; 65(6 Pt A):728-736. PubMed ID: 27425599 [TBL] [Abstract][Full Text] [Related]
4. Nanoliposomal Buparvaquone Immunomodulates Leishmania infantum-Infected Macrophages and Is Highly Effective in a Murine Model. da Costa-Silva TA; Galisteo AJ; Lindoso JA; Barbosa LR; Tempone AG Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167544 [TBL] [Abstract][Full Text] [Related]
5. T-cell populations and cytokine expression are impaired in thymus and spleen of protein malnourished BALB/c mice infected with Leishmania infantum. Cuervo-Escobar S; Losada-Barragán M; Umaña-Pérez A; Porrozzi R; Saboia-Vahia L; Miranda LH; Morgado FN; Menezes RC; Sánchez-Gómez M; Cuervo P PLoS One; 2014; 9(12):e114584. PubMed ID: 25535967 [TBL] [Abstract][Full Text] [Related]
7. Human Interleukin-32γ Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice. Gomes RS; Silva MVT; Dos Santos JC; van Linge C; Reis JM; Teixeira MM; Pinto SA; Dorta ML; Bai X; Chan ED; Dinarello CA; Oliveira MAP; Joosten LAB; Ribeiro-Dias F Infect Immun; 2018 May; 86(5):. PubMed ID: 29483288 [TBL] [Abstract][Full Text] [Related]
8. Interleukin 17A acts synergistically with interferon γ to promote protection against Leishmania infantum infection. Nascimento MS; Carregaro V; Lima-Júnior DS; Costa DL; Ryffel B; Duthie MS; de Jesus A; de Almeida RP; da Silva JS J Infect Dis; 2015 Mar; 211(6):1015-26. PubMed ID: 25274569 [TBL] [Abstract][Full Text] [Related]
9. In vivo antileishmanial activity and histopathological evaluation in Leishmania infantum infected hamsters after treatment with a furoxan derivative. de Almeida L; Passalacqua TG; Dutra LA; Fonseca JNVD; Nascimento RFQ; Imamura KB; de Andrade CR; Dos Santos JL; Graminha MAS Biomed Pharmacother; 2017 Nov; 95():536-547. PubMed ID: 28866421 [TBL] [Abstract][Full Text] [Related]
10. Identification of regulatory T cells during experimental Leishmania infantum infection. Rodrigues OR; Marques C; Soares-Clemente M; Ferronha MH; Santos-Gomes GM Immunobiology; 2009; 214(2):101-11. PubMed ID: 19167988 [TBL] [Abstract][Full Text] [Related]
11. Leishmania infantum: soluble proteins released by the parasite exert differential effects on host immune response. Rosa R; Rodrigues OR; Marques C; Santos-Gomes GM Exp Parasitol; 2005 Feb; 109(2):106-14. PubMed ID: 15687017 [TBL] [Abstract][Full Text] [Related]
12. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial. Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339 [TBL] [Abstract][Full Text] [Related]
13. The importance of TGF-beta in murine visceral leishmaniasis. Wilson ME; Young BM; Davidson BL; Mente KA; McGowan SE J Immunol; 1998 Dec; 161(11):6148-55. PubMed ID: 9834100 [TBL] [Abstract][Full Text] [Related]
14. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections. Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684 [TBL] [Abstract][Full Text] [Related]
15. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani. Engwerda CR; Murphy ML; Cotterell SE; Smelt SC; Kaye PM Eur J Immunol; 1998 Feb; 28(2):669-80. PubMed ID: 9521077 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis. Islamuddin M; Chouhan G; Want MY; Ozbak HA; Hemeg HA; Afrin F PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005011. PubMed ID: 27776125 [TBL] [Abstract][Full Text] [Related]
18. Behavior of two Leishmania infantum strains-evaluation of susceptibility to antimonials and expression of microRNAs in experimentally infected J774 macrophages and in BALB/c mice. Silva SC; Silva DF; Almeida TC; Perasoli FB; da Silva ATP; da Silva GN; Rezende SA Parasitol Res; 2018 Sep; 117(9):2881-2893. PubMed ID: 29943317 [TBL] [Abstract][Full Text] [Related]
19. Infection pattern and immune response in the spleen and liver of BALB/c mice intracardially infected with Leishmania donovani amastigotes. Mukherjee P; Ghosh AK; Ghose AC Immunol Lett; 2003 Apr; 86(2):131-8. PubMed ID: 12644314 [TBL] [Abstract][Full Text] [Related]
20. Phenotypical Characterization of Spleen Remodeling in Murine Experimental Visceral Leishmaniasis. de Melo CVB; Hermida MD; Mesquita BR; Fontes JLM; Koning JJ; Solcà MDS; Benevides BB; Mota GBS; Freitas LAR; Mebius RE; Dos-Santos WLC Front Immunol; 2020; 11():653. PubMed ID: 32351510 [No Abstract] [Full Text] [Related] [Next] [New Search]